InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Buckheit Robert, Cadre. Director active across 1 company, notably Cytocom, Inc.. Cumulatively, 2 reports have been published. Activity tracked since 27 July 2021. The latest transaction was filed on 27 July 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Robert Buckheit is Chief Technology Officer at Cytocom, Inc. In this role, he is responsible for managing technology and innovation within the company. Buckheit plays a key role in developing new technological solutions and optimizing operational processes. His expertise in technology is essential for Cytocom's success.